A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia
NCT00209937 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 675
Last updated 2007-03-30
Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia
Conditions
- Primary Insomnia
Interventions
- DRUG
-
Gaboxadol
Sponsors & Collaborators
-
H. Lundbeck A/S
lead INDUSTRY
Principal Investigators
-
Please contact: Annelies van der Hammen Legters · H. Lundbeck A/S
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Completion
- 2004-06-30
More Related Trials
-
Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)
NCT00102167 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)
NCT00102154 ·Status: WITHDRAWN ·Phase: PHASE3
-
Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)
NCT00094666 ·Status: TERMINATED ·Phase: PHASE3
-
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)
NCT00266357 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
NCT00095043 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)
NCT00095069 ·Status: COMPLETED ·Phase: PHASE3
-
MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)
NCT00266344 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
NCT00103818 ·Status: COMPLETED ·Phase: PHASE3
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423 ·Status: COMPLETED ·Phase: PHASE2
-
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00280436 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
NCT00569972 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
NCT00354809 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
NCT00551148 ·Status: COMPLETED ·Phase: PHASE2
-
Treatments for Insomnia in Patients With Parkinson's Disease
NCT01489982 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00426816 ·Status: COMPLETED ·Phase: PHASE2
-
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
NCT00608985 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
NCT00666575 ·Status: COMPLETED ·Phase: PHASE3
-
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
NCT00177216 ·Status: COMPLETED ·Phase: PHASE4
-
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
NCT00420810 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of EVT 201 to Treat Insomnia
NCT00380003 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia
NCT00755495 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
NCT02839200 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
NCT03375203 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
NCT00784875 ·Status: COMPLETED ·Phase: PHASE2